ANIK ANIKA THERAPEUTICS INC revenue, earnings and financials

For the quarter ended June 30, 2026, ANIKA THERAPEUTICS INC reported revenue of $32.6M (up 15.6% from a year earlier), net income of $3.31M and diluted EPS of $0.24; over the last four quarters revenue was $121M and net income −$3.90M; for the fiscal year ended December 2025 revenue was $113M, down 5.9% on the year before.

ANIK annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $113M, gross profit $63.8M, operating income −$11.1M, net income −$11.0M (margin -9.8%), EPS −$0.76
• Fiscal year ended Dec 2024: revenue $120M, gross profit $76.0M, operating income −$5.10M, net income −$56.0M (margin -46.7%), EPS −$3.83
• Fiscal year ended Dec 2023: revenue $121M, gross profit $82.5M, operating income $844K, net income −$83.0M (margin -68.7%), EPS −$5.64
• Fiscal year ended Dec 2022: revenue $114M, gross profit $73.2M, operating income $3.67M, net income −$15.0M (margin -13.2%), EPS −$1.02
• Fiscal year ended Dec 2021: revenue $148M, gross profit $82.9M, operating income $2.62M, net income $4.00M (margin 2.7%), EPS $0.28

ANIK quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $32.6M (up 15.6% year over year), net income $3.31M, EPS $0.24
• Quarter ended Mar 31, 2026: revenue $29.6M (up 13.2% year over year), net income −$5.06M, EPS −$0.37
• Quarter ended Dec 31, 2025 (from the annual report): revenue $30.6M (up 0.0% year over year), net income $172K, EPS $0.02
• Quarter ended Sep 30, 2025: revenue $27.8M (down 5.9% year over year), net income −$2.33M, EPS −$0.16
• Quarter ended Jun 30, 2025: revenue $28.2M (down 8.2% year over year), net income −$3.97M, EPS −$0.28
• Quarter ended Mar 31, 2025: revenue $26.2M (down 9.8% year over year), net income −$4.87M, EPS −$0.34
• Quarter ended Dec 31, 2024 (from the annual report): revenue $30.6M (up 1155.6% year over year), net income −$21.5M, EPS −$1.49
• Quarter ended Sep 30, 2024: revenue $29.6M (down 28.7% year over year), net income −$29.9M, EPS −$2.03
• Quarter ended Jun 30, 2024: revenue $30.7M (down 30.6% year over year), net income −$88.0K, EPS $0.00
• Quarter ended Mar 31, 2024: revenue $29.0M (down 23.5% year over year), net income −$4.51M, EPS −$0.31
• Quarter ended Dec 31, 2023 (from the annual report): revenue −$2.90M (down 4.0% year over year), net income −$63.3M, EPS −$4.29
• Quarter ended Sep 30, 2023: revenue $41.5M (up 3.0% year over year), net income −$6.58M, EPS −$0.45
• Quarter ended Jun 30, 2023: revenue $44.3M (up 11.7% year over year), net income −$2.74M, EPS −$0.19
• Quarter ended Mar 31, 2023: revenue $37.9M (up 3.4% year over year), net income −$10.4M, EPS −$0.71
• Quarter ended Dec 31, 2022 (from the annual report): revenue −$2.79M (down 107.8% year over year), net income −$5.05M, EPS −$0.33
• Quarter ended Sep 30, 2022: revenue $40.3M (up 1.8% year over year), net income −$4.18M, EPS −$0.29
• Quarter ended Jun 30, 2022: revenue $39.7M (up 4.0% year over year), net income −$2.84M, EPS −$0.20
• Quarter ended Mar 31, 2022: revenue $36.7M (up 7.0% year over year), net income −$2.93M, EPS −$0.20
• Quarter ended Dec 31, 2021 (from the annual report): revenue $35.8M, net income −$5.93M, EPS −$0.41
• Quarter ended Sep 30, 2021: revenue $39.5M, net income $558K, EPS $0.04

ANIK cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $11.2M, share buybacks $9.49M
• Fiscal year ended Dec 2024: operating cash flow $5.40M, share buybacks $10.9M
• Fiscal year ended Dec 2023: operating cash flow −$1.79M, share buybacks $5.00M
• Fiscal year ended Dec 2022: operating cash flow $4.41M, share buybacks $0
• Fiscal year ended Dec 2021: operating cash flow $8.40M, share buybacks $0

ANIK balance sheet

• Jun 30, 2026: cash $38.4M, total assets $183M, total liabilities n/a, shareholders' equity $137M
• Mar 31, 2026: cash $41.0M, total assets $179M, total liabilities n/a, shareholders' equity $134M
• Dec 31, 2025: cash $57.5M, total assets $190M, total liabilities n/a, shareholders' equity $143M
• Sep 30, 2025: cash $58.0M, total assets $189M, total liabilities n/a, shareholders' equity $147M
• Jun 30, 2025: cash $53.2M, total assets $188M, total liabilities n/a, shareholders' equity $148M
• Mar 31, 2025: cash $53.4M, total assets $191M, total liabilities n/a, shareholders' equity $148M
• Dec 31, 2024: cash $55.6M, total assets $203M, total liabilities n/a, shareholders' equity $154M
• Sep 30, 2024: cash $62.4M, total assets $231M, total liabilities n/a, shareholders' equity $180M

What is ANIK's revenue?

ANIKA THERAPEUTICS INC reported $121M of revenue over its last four quarters, through June 30, 2026.

Is ANIK profitable?

No. ANIKA THERAPEUTICS INC lost $3.90M over the last four quarters.

What is ANIK's EPS?

Diluted earnings per share over the last four quarters were −$0.27; $0.24 in the latest quarter.

ANIK ownership and insider trades · All stocks